Sign Up Today and Learn More About Terray Therapeutics Stock
Invest in or calculate the value of your shares in Terray Therapeutics or other pre-IPO companies through EquityZen's platform.
Terray Therapeutics Stock (TEAT)
Terray Therapeutics is a biotechnology company that propels drug discovery into the information age.
About Terray Therapeutics Stock
Founded
2018
Headquarters
Pasadena, CA, US
Industries
Software, Data and Analytics, Science and Engineering
Terray Therapeutics is a biotechnology company that propels drug discovery into the information age. It is led by leaders in artificial intelligence, synthetic (medicinal) chemistry, biology, preclinical development, automation, and nanotechnology. Chemical datasets generated with its novel ultra-dense microarray technology integrate seamlessly with its integrated machine learning and computational platform to map biochemical interactions between small molecules and disease causes. AI and machine learning models are powered by iterative cycles of virtual molecular design and experimentation, which in turn guide the next design cycle. The company was founded in 2018 and is based in Pasadena, California.
Terray Therapeutics Press Mentions
Stay in the know about the latest news on Terray Therapeutics
Gilead and Terray Therapeutics Announce Multi-Target Research Collaboration to Discover and Develop Novel Small Molecule Therapies
finance • Dec 28, 2024
Odyssey Therapeutics and Terray Therapeutics Enter Strategic Collaboration to Jointly Discover and Develop First-in-Class Transcription Factor Therapies
finance • Dec 28, 2024
Gilead inks multi-target deal with Terray Therapeutics
thepharmaletter • Dec 18, 2024
Gilead and Terray Therapeutics collaborate on drug discovery
bioworld • Dec 18, 2024
Gilead, Terray to collaborate on small molecule drugs
seekingalpha • Dec 18, 2024
Terray Therapeutics Management
Leadership team at Terray Therapeutics
Associate Data Scientist
Taline Mardirossian
Board Member
Geoffrey W. Smith
Join now and verify your accreditation status to gain access to:
- Terray Therapeutics current valuation
- Terray Therapeutics stock price
- Available deals in Terray Therapeutics and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
Trading Terray Therapeutics Stock
How to invest in Terray Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Terray Therapeutics through EquityZen funds. These investments are made available by existing Terray Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Terray Therapeutics stock?
Shareholders can sell their Terray Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 340K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 44K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
